Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Tuohua Biotechnology is a clinical-stage molecular diagnostics company headquartered in the Suzhou Industrial Park, China. The company specializes in the research, development, and manufacturing of high-precision in vitro diagnostic (IVD) solutions, with a primary focus on reproductive health, genetic screening, and oncology. Utilizing its proprietary multi-color fluorescence quantitative PCR platform, Tuohua Biotech has commercialized a robust portfolio of products, including diagnostic kits for Human Papillomavirus (HPV) genotyping, thalassemia screening, and Y-chromosome microdeletion detection. The company operates a GMP-compliant manufacturing facility and maintains strong collaborations with clinical institutions to advance precision medicine. Tuohua Biotech is dedicated to providing accessible and accurate genetic testing to improve maternal and child health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州拓华生物科技.